Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally. The company is headquartered in Plano, Texas.
| Revenue (TTM) | $1.83B |
| Gross Profit (TTM) | $457.53M |
| EBITDA | $318.58M |
| Operating Margin | 8.26% |
| Return on Equity | 5.97% |
| Return on Assets | 3.30% |
| Revenue/Share (TTM) | $53.22 |
| Book Value | $50.78 |
| Price-to-Book | 2.49 |
| Price-to-Sales (TTM) | 2.36 |
| EV/Revenue | 3.087 |
| EV/EBITDA | 20.15 |
| Quarterly Earnings Growth (YoY) | -61.30% |
| Quarterly Revenue Growth (YoY) | -3.90% |
| Shares Outstanding | $34.00M |
| Float | $28.90M |
| % Insiders | 0.90% |
| % Institutions | 134.01% |
Volatility is currently expanding
Integer (ITGR) came out with quarterly earnings of $1.34 per share, missing the Zacks Consensus Estimate of $1.65 per share. This compares to earnings of $1.79 per share a year ago.
PLANO, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended October 2, 2026. Third Quarter 2026 Highlights (compared to Third Quarter 2025, except as noted) Sales decreased 3.9% to $450 million.
Investors need to pay close attention to ITGR stock based on the movements in the options market lately.
PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2026, and ending at the close of business on December 31, 2026. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted.
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks offers value investors a better bang for their buck right now?
ITGR's $127-a-share KKR deal offers defined cash value, while core franchises face slow new-product adoption.
LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Integer Holdings Corporation (“Integer” or “the Company”) (NYSE: ITGR) for potential breaches of fiduciary duty on the part of its directors and management.
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Integer (ITGR). But which of these two companies is the best option for those looking for undervalued stocks?
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Integer Holdings Corporation (“Integer” or “the Company”) (NYSE: ITGR) for potential breaches of fiduciary duty on the part of its directors and management.
Integer's $5.7 billion KKR buyout offers shareholders $127 per share in cash, but closing still hinges on stockholder and regulatory approvals.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ITGR and any ticker you trade — then tracks every position and per-strategy win rate.
